UCB Ventures and Ysios Capital have led a EUR 50m Series A for SpliceBio, a Spanish biotech company working on protein splicing for gene therapies.
UCB Ventures and Ysios Capital have led a EUR 50m Series A for SpliceBio, a Spanish biotech company working on protein splicing for gene therapies.